Dispatches from Bio Digital 2021 Mogrify looks to transform cell therapy development 01-Jul-2021 By Jane Byrne Biotech, Mogrify, recently closed a Series A financing of US$17m, bringing the total raised to US$33m in the round, with the investment set to support the advancement of the company’s immuno-oncology and ophthalmology programs.